Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Pre-Close Trading Update for year ended 30 September 2018

IXICO
Posted on: 17 Oct 18

 

Revenue increased by 32% to £5.4m

Strong closing cash balance of £7.9m

 

IXICO plc (AIM: IXI), the data science company delivering insights in neuroscience, today provides the following pre-close trading update ahead of its preliminary results for the year ended 30 September 2018.

 

The Company is pleased to announce that revenue increased by £1.3 million or 32% to £5.4 million (2017: £4.1 million). Excluding the impact of foreign exchange, the underlying revenue of £5.1 million (2017: £3.8 million) increased by 34%. This revenue growth included an expansion of medical imaging services provided to global pharmaceutical clients in new and existing projects, together with preliminary revenue from wearable biosensor projects.

 

During the year the Company announced several new multi-year contracts which are worth a combined total of over £15.0 million, including a Phase III contract signed at the end of the financial year. These new contracts and existing projects, provide a foundation for future revenue growth.

 

Total income increased by 25% to £6.0 million (2017: £4.8 million) as Other income of £0.6 million (2017: £0.6 million) was in line with the prior year.

 

Net cash at 30 September 2018 was £7.9 million (2017:  £2.4 million) and reflected an over-subscribed placing of £5.5 million in May 2018, which will be used to accelerate the Company’s commercially led growth strategy. Second half cash inflows also included R&D tax credit receipt of £0.4 million and reimbursement of grant costs.

 

The Company anticipates that its preliminary results to 30 September 2018 will be announced on 4 December 2018.

 

For further information please contact:

 

IXICO plc

Giulio Cerroni, Chief Executive Officer

Susan Lowther, Chief Financial Officer

 

Tel: +44 20 3763 7499

 

 

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 17/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.